Globe Life (NYSE:GL) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Globe Life (NYSE:GL) issued its quarterly earnings results on Wednesday. The company reported $3.14 EPS for the quarter, topping analysts’ consensus estimates of $3.12 by $0.02, Zacks reports. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. Globe Life updated its FY 2025 guidance to 13.450-14.050 EPS.

Globe Life Stock Performance

Shares of Globe Life stock traded up $1.52 during midday trading on Friday, hitting $121.49. The company had a trading volume of 387,847 shares, compared to its average volume of 558,366. Globe Life has a 12-month low of $38.95 and a 12-month high of $132.00. The company has a fifty day simple moving average of $112.95 and a 200 day simple moving average of $106.62. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The stock has a market cap of $10.20 billion, a price-to-earnings ratio of 10.27 and a beta of 0.81.

Globe Life Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were given a $0.24 dividend. The ex-dividend date of this dividend was Monday, January 6th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.79%. Globe Life’s payout ratio is 8.12%.

Insider Buying and Selling at Globe Life

In related news, CEO Frank M. Svoboda sold 13,448 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $112.56, for a total value of $1,513,706.88. Following the completion of the sale, the chief executive officer now owns 18,948 shares of the company’s stock, valued at approximately $2,132,786.88. This represents a 41.51 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Mark A. Blinn sold 3,000 shares of Globe Life stock in a transaction on Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the completion of the sale, the director now owns 5,122 shares in the company, valued at $579,964.06. This represents a 36.94 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 39,788 shares of company stock worth $4,429,779. 1.51% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have recently commented on GL. Wells Fargo & Company raised their price target on Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a report on Thursday, October 10th. Jefferies Financial Group increased their target price on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Keefe, Bruyette & Woods increased their target price on shares of Globe Life from $135.00 to $137.00 and gave the stock an “outperform” rating in a report on Friday, January 10th. BMO Capital Markets initiated coverage on shares of Globe Life in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $114.00 price target for the company. Finally, Evercore ISI upgraded shares of Globe Life from an “in-line” rating to an “outperform” rating and boosted their target price for the company from $132.00 to $143.00 in a report on Wednesday, January 8th. Five research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $132.18.

Globe Life Company Profile

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.